PS

Prateek Sachdeva

Active Director Director DIN 09567575
DIN 09567575 First appointment Apr 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Prateek Sachdeva

Data last updated:

Prateek Sachdeva is a Director at Medion Biotech Private Limited (since 2022). The company operates in Pharma. Medion Biotech Private Limited reported revenue of ₹29.50 Cr (FY 2025).

DIN 09567575
Primary Designation Director
Industry Pharma
First Appointment 11 Apr 2022
Oldest Company Age 14 yrs
Largest company Medion Biotech Private Limited · ₹29.50 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medion Biotech Private Limited U51909DL2012PTC234100
Director11 Apr 20222012₹29.50 Cr (FY 2025)Active

Board colleagues of Prateek Sachdeva

Directorship timeline

Open interactive timeline →
Medion Biotech Private Limited
Premium access

Shareholding and investment profile for Prateek Sachdeva

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prateek Sachdeva

Prateek Sachdeva currently holds 1 directorship: Medion Biotech Private Limited (Director, since 11 Apr 2022, revenue ₹29.50 Cr (FY 2025)).

Prateek Sachdeva was first appointed on 11 Apr 2022 as Director at Medion Biotech Private Limited.

The current boards of Prateek Sachdeva's companies include Kapil Dev (Medion Biotech Private Limited), Ram Bujhawan (Medion Biotech Private Limited), Rinku Kumari (Medion Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available